🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Francis J. Giles

ORCID: 0000-0002-6919-0231

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Moxetumomab pasudotox in heavily pre-treated patients with relapsed/refractory hairy cell leukemia (HCL): long-term follow-up from the pivotal trial”.

Moxetumomab pasudotox in heavily pre-treated patients with relapsed/refractory hairy cell leukemia (HCL): long-term follow-up from the pivotal trial

Journal of Hematology & Oncology(2021)10.1186/s13045-020-01004-y

N/A

1.9DataRank · unranked

86 citations

Robert J. Kreitman, Claire Dearden, Pier Luigi Zinzani, Julio Delgado, Tadeusz Robak +14 more

A first-in-human phase 0 clinical study of RNA interference–based spherical nucleic acids in patients with recurrent glioblastoma

Science Translational Medicine(2021)10.1126/scitranslmed.abb3945

N/A

0DataRank · unranked

327 citations

Caroline H. Ko, Tatjana Paunesku, Karan Dixit, Adam M. Sonabend, Orin Bloch +32 more

Dual inhibition of BET and HAT/p300 suppresses colorectal cancer via DR5- and p53/PUMA-mediated cell death

Frontiers in Oncology(2022)10.3389/fonc.2022.1018775

N/A

0DataRank · unranked

12 citations

Jingshan Tong, Kaylee Ermine, Manbo Cai, Fujun Dai, Suisui Hao +5 more

GSK-3 Inhibitor Elraglusib Enhances Tumor-Infiltrating Immune Cell Activation in Tumor Biopsies and Synergizes with Anti-PD-L1 in a Murine Model of Colorectal Cancer

International Journal of Molecular Sciences(2023)10.3390/ijms241310870

N/A

0DataRank · unranked

25 citations

Anna D. Louie, Praveen R. Srinivasan, Christoph Schorl, Shaolei Lu, David Silverberg +9 more

GSK-3 inhibitor elraglusib enhances tumor-infiltrating immune cell activation in tumor biopsies and synergizes with anti-PD-L1 in a murine model of colorectal cancer

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.02.07.527499

N/A

0DataRank · unranked

6 citations

Anna D. Louie, Praveen R. Srinivasan, Christoph Schorl, Shaolei Lu, David Silverberg +9 more

GSK-3 inhibitor elraglusib (9-ING-41) to enhance tumor-infiltrating immune cell activation in tumor biopsies and synergize with anti-PD-L1 in a murine model of colorectal cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e15138

N/A

0DataRank · unranked

1 citations

Kelsey E. Huntington, Anna D. Louie, Praveen Srinivasan, Cristoph Schorl, Shaolei Lu +10 more